Literature DB >> 18645958

Effects of the disruption of the HSP70-II gene on the growth, morphology, and virulence of Leishmania infantum promastigotes.

Cristina Folgueira1, Javier Carrión, Javier Moreno, Jose M Saugar, Carmen Cañavate, Jose M Requena.   

Abstract

The 70-kDa heat shock protein (HSP70) is highly conserved among both prokaryotes and eukaryotes and plays essential roles in diverse cellular functions not only under stress but also under normal conditions. In the protozoan Leishmania infantum, the causative agent of visceral leishmaniasis, HSP70 is encoded by two HSP70 genes. Here, we describe the phenotypic alterations of HSP70-II-deficient (Deltahsp70-II) promastigotes. The absence of HSP70-II caused a major alteration in growth as the promastigotes reached stationary phase. In addition, aberrant forms were frequently observed in Deltahsp70-II mutant cultures. An accumulation of cells in the G2/M phase in cultures of the Deltahsp70-II mutant was determined by flow cytometry. Furthermore, Deltahsp70-II promastigotes showed a limited capacity of multiplication within macrophages, even though attachment to and uptake by macrophages did not differ significantly from the wild-type. Moreover, Deltahsp70-II was highly attenuated in BALB/c mouse experimental infections. In mutants re-expressing HSP70-II, the growth rate was restored, the normal morphology was recovered, and interactions with macrophages increased. However, promastigotes re-expressing HSP70-II did not recover their virulence. Overall, these data highlight the essential role played by HSP70-II expression in Leishmania virulence, pointing to this gene as a promising target for therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18645958

Source DB:  PubMed          Journal:  Int Microbiol        ISSN: 1139-6709            Impact factor:   2.479


  10 in total

1.  Repurposing of known drugs for leishmaniasis treatment using bioinformatic predictions, in vitro validations and pharmacokinetic simulations.

Authors:  Christian Bustamante; Rodrigo Ochoa; Claudia Asela; Carlos Muskus
Journal:  J Comput Aided Mol Des       Date:  2019-10-14       Impact factor: 3.686

2.  Knockdown of LdMC1 and Hsp70 by antisense oligonucleotides causes cell-cycle defects and programmed cell death in Leishmania donovani.

Authors:  Puneet Raina; Sukhbir Kaur
Journal:  Mol Cell Biochem       Date:  2011-07-31       Impact factor: 3.396

3.  Mechanisms of action of substituted β-amino alkanols on Leishmania donovani.

Authors:  María Ángeles Abengózar; Luis A Bustos; Raquel García-Hernández; Pilar Fernández de Palencia; Ricardo Escarcena; Santiago Castanys; Esther del Olmo; Francisco Gamarro; Arturo San Feliciano; Luis Rivas
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

4.  Host cell invasion and virulence mediated by Candida albicans Ssa1.

Authors:  Jianing N Sun; Norma V Solis; Quynh T Phan; Jashanjot S Bajwa; Helena Kashleva; Angela Thompson; Yaoping Liu; Anna Dongari-Bagtzoglou; Mira Edgerton; Scott G Filler
Journal:  PLoS Pathog       Date:  2010-11-11       Impact factor: 6.823

5.  Proteomic analysis reveals differentially abundant proteins probably involved in the virulence of amastigote and promastigote forms of Leishmania infantum.

Authors:  Luiz Fialho Junior; Simone da Fonseca Pires; Richard Burchmore; Suzanne McGill; Stefan Weidt; Jeronimo Conceição Ruiz; Frederico Goncalves Guimarães; Alexander Chapeourouge; Jonas Perales; Hélida Monteiro de Andrade
Journal:  Parasitol Res       Date:  2021-01-08       Impact factor: 2.289

6.  Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation.

Authors:  Javier Carrión; Cristina Folgueira; Manuel Soto; Manuel Fresno; Jose M Requena
Journal:  Parasit Vectors       Date:  2011-07-27       Impact factor: 3.876

Review 7.  Molecular Chaperones of Leishmania: Central Players in Many Stress-Related and -Unrelated Physiological Processes.

Authors:  Jose M Requena; Ana M Montalvo; Jorge Fraga
Journal:  Biomed Res Int       Date:  2015-06-18       Impact factor: 3.411

8.  HSP70 of Leishmania amazonensis alters resistance to different stresses and mitochondrial bioenergetics.

Authors:  Bárbara Santoni Codonho; Solange Dos Santos Costa; Eduardo de Figueiredo Peloso; Paulo Pinto Joazeiro; Fernanda Ramos Gadelha; Selma Giorgio
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-06-10       Impact factor: 2.743

9.  Vaccination with a Leishmania infantum HSP70-II null mutant confers long-term protective immunity against Leishmania major infection in two mice models.

Authors:  José Carlos Solana; Laura Ramírez; Laura Corvo; Camila Indiani de Oliveira; Manoel Barral-Netto; José María Requena; Salvador Iborra; Manuel Soto
Journal:  PLoS Negl Trop Dis       Date:  2017-05-30

10.  MAPK1 of Leishmania donovani interacts and phosphorylates HSP70 and HSP90 subunits of foldosome complex.

Authors:  Pavneet Kaur; Mansi Garg; Antje Hombach-Barrigah; Joachim Clos; Neena Goyal
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.